donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 01931 IVD Medical > Key Indicators
01931 IVD Medical
2.390
-0.010-0.42%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Per Share IndicaTor
Operating Cash Flow Per Share
-3.7% 0.1474 109.64% 0.0183 -46.32% 0.1531 -1077.24% -0.1901
Cash Flow Per Share
178.19% 0.0623 374.89% 0.0827 -112% -0.0797 -109.2% -0.0301
Operating Income Per Share
13.2% 2.4685 30.85% 1.0542 11.66% 2.1807 -22.36% 0.8056
Net Asset Per Share
5.17% 2.6929 11.1% 2.5748 8.51% 2.5606 0.58% 2.3174
Basic Earning Per Share
13.81% 0.1613 127.97% 0.0716 -47.64% 0.1417 -99.37% 0.0314
Diluted  Earning Per Share
12.31% 0.1583 125.7% 0.0707 -41.23% 0.1409 -99.37% 0.0313
Profitability
Gross Profit Ratio
5.75% 20.737% 2.14% 20.213% 3.29% 19.610% -16.05% 19.789%
Operating Profit Ratio
0.37% 9.536% 56.7% 10.106% -24.83% 9.501% -59.09% 6.449%
Net Profit Ratio
-6.97% 5.923% 77.22% 6.519% -41.71% 6.368% -90.43% 3.678%
Earning Before Tax Ratio
2.72% 9.812% 62.97% 10.024% -24.96% 9.553% -85.77% 6.151%
ROE
5.2% 6.072% 105.33% 2.760% -60.22% 5.772% -94.33% 1.344%
ROA
1.62% 4.276% 103.03% 1.944% -62.23% 4.208% -94.13% 0.958%
Yield Quality
Operating Profit To Total Profits
-2.29% 97.188% -3.84% 100.826% 0.17% 99.463% 187.52% 104.855%
Tax To Total Profits
18.87% 39.632% -13.01% 34.968% 135.05% 33.342% 261.61% 40.198%
Operating Cash To Total Revenue
-14.93% 5.973% 107.37% 1.739% -51.93% 7.021% -1358.68% -23.602%
Capital Structure
Debt Assets Ratio
17.31% 31.459% 3.36% 31.661% -2.46% 26.818% -19.82% 30.633%
Equity Multipler
6.99% 1.4661 2.28% 1.4666 -0.2% 1.3704 -11.58% 1.434
Debt Equity Ratio
25.25% 45.899% 4.91% 46.329% -3.36% 36.646% -28.58% 44.160%
Current Assets To tatal Assets
7.64% 57.971% 1.24% 57.337% -2.73% 53.857% 17.08% 56.634%
Non Current Assets To Total Assets
-8.92% 42.029% -1.62% 42.663% 3.38% 46.143% -16% 43.366%
Current Liabilities To tatal Liabilities
27.57% 84.130% 0.67% 84.299% -18.59% 65.946% -0.17% 83.734%
Non Current Liabilities To Total Liabilities
-53.4% 15.870% -3.47% 15.701% 79.28% 34.054% 0.9% 16.266%
Solvency
Current Ratio
-28.07% 2.1903 -2.7% 2.1483 22.49% 3.0452 46.28% 2.208
Quick Ratio
-30.02% 1.6084 6.69% 1.6303 30% 2.2984 91.94% 1.5281
Operating Profit To Current Liabilities
-32.53% 0.2253 73.42% 0.1057 -2.39% 0.3339 -55.37% 0.061
Operrating Cash Flow To Current Liabilities
-42.81% 0.1411 108.16% 0.0182 -37.58% 0.2467 -1472.91% -0.2231
Share Equity Without Minority Interest To Total Liabilities
-20.32% 2.1681 -5.4% 2.1536 2.72% 2.721 41.06% 2.2765
Operating Cash Flow To Total Liabilities
-27.04% 0.1187 108.21% 0.0153 -49.18% 0.1627 -1470.5% -0.1868
Operating Profit To Total Liabilities
-13.92% 0.1895 74.59% 0.0891 -20.54% 0.2202 -55.45% 0.051
Operating Capacity
Inventory Turnover(T)
3.66% 3.6872 46.51% 1.725 -36.8% 3.5571 -32.22% 1.1774
Current Assets Turnover(T)
1.19% 1.1935 19.87% 0.5254 -36.33% 1.1794 -52.97% 0.4383
Fixed Assets Turnover(T)
19.31% 35.0559 19.33% 14.5331 -20.25% 29.3831 -30.84% 12.1785
Total Assets Turnover(T)
3.92% 0.669 19.16% 0.2925 -31.89% 0.6438 -41.72% 0.2455
Growth Ability
Operating Revenue GR 3Y
-0.89% 607.480% -- -- -12.69% 612.949% -- --
Gross Income GR 3Y
24.66% 420.141% -- -- -21.09% 337.026% -- --
Operating Profit GR 3Y
73.57% 542.602% -- -- -61.95% 312.611% -- --
EBT GR 3Y
81.21% 144.124% -- -- -77.2% 79.533% -- --
Net Profit GR 3Y
103.92% 74.200% -- -- -89.46% 36.386% -- --
Net Profit Attributable To The Parent Company GR 3Y
90.84% 80.830% -- -- -89.08% 42.356% -- --
Total Assets GR 3Y
11.19% 348.967% -- -- -14.45% 313.844% -- --
Share Equity Without Minority Interest GR 3Y
0.22% 235.791% -- -- -15.49% 235.283% -- --
Equity GR 3Y
1.4% 234.871% -- -- -14.85% 231.636% -- --
Total Liabilities GR 3Y
39.3% 1642.292% -- -- -10.97% 1178.966% -- --
Basic Earning Per Share GR 3Y
1.64% -92.861% -- -- -8.72% -94.411% -- --
Other Indicators
Currency Unit
HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
China Inspection Medical Holdings Co., Ltd. is a Chinese company mainly engaged in selling in vitro diagnostic products (IVD). The company's distribution business is mainly engaged in the sale of IVD analyzers and IVD reagents and other consumables. The company's own-brand product business is mainly engaged in research, development, production and sales of own-brand IVD products. The company also provides maintenance services for its own products.
CEO: Jucheng He
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...